Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

The UK economy could receive a boost of more than £4 billion by helping people considered obese access weight loss jabs to get back to work, with four million people said to be eligible ...

Are you a fan of this popular spice? A doctor explains why sprinkling cinnamon in your coffee is probably OK, but taking ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Numerous studies affirm a truth so many of us have experienced firsthand: Sooner or later, almost every weight-loss plan ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Ozempic is what's known as a GLP-1, a drug class that's prescribed to manage Type 2 diabetes and is effective for weight loss ...

Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.